These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 378580

  • 21. Dantrolene sodium: an effective therapeutic agent for the treatment of spasticity in children.
    García-Castro JM.
    Bol Asoc Med P R; 1977 Aug; 69(8):263-5. PubMed ID: 334191
    [No Abstract] [Full Text] [Related]

  • 22. Action of dantrolene sodium in spasticity with low dependence on fusimotor drive.
    Knutsson E, Martensson A.
    J Neurol Sci; 1976 Oct; 29(2-4):195-212. PubMed ID: 135820
    [Abstract] [Full Text] [Related]

  • 23. [Dantrolene in juvenile spasticity: 3 months of daily observation].
    Berruti P.
    Riv Neurol; 1979 Oct; 49(1):30-52. PubMed ID: 451397
    [Abstract] [Full Text] [Related]

  • 24. Effect of dantrolene sodium on spasticity associated with hemiplegia.
    Steinberg FU, Ferguson KL.
    J Am Geriatr Soc; 1975 Feb; 23(2):70-3. PubMed ID: 1141624
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Dantrolene sodium (Dantrium-Eaton) for relief of spasticity.
    Nelson JR.
    West J Med; 1975 Aug; 123(2):131. PubMed ID: 1179721
    [No Abstract] [Full Text] [Related]

  • 27. Treatment of spasticity in multiple sclerosis: comparison of dantrolene sodium and diazepam.
    Schmidt RT, Lee RH, Spehlmann R.
    Trans Am Neurol Assoc; 1975 Aug; 100():235-7. PubMed ID: 1226625
    [No Abstract] [Full Text] [Related]

  • 28. Long-term treatment of spasticity in children with cerebral palsy.
    Molnar GE.
    Int Disabil Stud; 1987 Aug; 9(4):170-2. PubMed ID: 3126178
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Dantrolene sodium in the treatment of spasticity.
    Basmajian JV, Super GA.
    Arch Phys Med Rehabil; 1973 Feb; 54(2):61-4 passim. PubMed ID: 4571174
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pharmacotherapy of spasticity in children with cerebral palsy.
    Chung CY, Chen CL, Wong AM.
    J Formos Med Assoc; 2011 Apr; 110(4):215-22. PubMed ID: 21540003
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Dantrium--torque induced motion ("TIM"). Analysis in normal subjects.
    Walsh EG.
    Agressologie; 1977 Apr; 18 Spec No():31-3. PubMed ID: 900358
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The management of cerebral palsy: subjectivity and a conundrum.
    Bodensteiner JB.
    J Child Neurol; 1996 Mar; 11(2):75-76. PubMed ID: 8881980
    [No Abstract] [Full Text] [Related]

  • 37. Letter: Dantrolene.
    Shaivitz SA.
    JAMA; 1974 Sep 02; 229(10):1282-3. PubMed ID: 4408254
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.